awmsg logo



ciclosporin (Verkazia®)


Reference No. 2908

Publication date:
06/03/2019


Appraisal information

ciclosporin (Verkazia®) 1 mg/ml eye drops


Company: Santen UK Ltd
BNF category: Eye
NMG meeting date: 09/01/2019
AWMSG meeting date: 13/02/2019
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 0219
Ratification by Welsh Government: 05/03/2019

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

Ciclosporin (Verkazia®) is recommended as an option for use within NHS Wales for the treatment of severe vernal keratoconjunctivitis in children from 4 years of age and adolescents (until the age of 18).
AWMSG Secretariat Appraisal Report (ASAR)
Download
Final Appraisal Recommendation (FAR)
Download